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Thrilling Monotony: An Erratic Narrative of my Establishment in Science
But let that man with better sence aduize,
That of the world least part to vs is red:
And dayly how through hardy enterprize,
Many great Regions are discouered,
Which to late age were neuer mentioned.
Who euer heard of th'Indian Peru?
Or who in venturous vessell measured
The Amazon huge riuer now found trew?
Or fruitfullest Virginia who did euer vew?
Yet all these were, when no man did them know;
Yet haue from wisest ages hidden beene:
And later times things more vnknowne shall show.
Why then should witlesse man so much misweene
That nothing is, but that which he hath seene?
What if within the Moones faire shining spheare?
What if in euery other starre vnseene
Of other worldes he happily should heare?
He wonder would much more: yet such to some appeare.
-Edmund Spenser, The Faery Queene, Book Two, Stanzas 2 & 3

NOTE TO THE READER: The above quotation is important for two reasons. Its primary
significance derives from the fact that it was this quotation that adorned the outside of my
cubical during my two months of summer research. Secondly, this quotation is drawn from
Spenser's 1590 masterpiece The Faerie Queene, a work that is possibly equal parts great and
confusing in its attempt to educate. Alas, the only real comparison I can make here is that my
narrative might also seem confusing. It might seem like an erratic narrative told with arbitrary
speed and detail, and that is probably because it is. It is simply a collection of some of the
experiences from my summer research that stood out to me. Most were included in this narrative
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because they served as pivotal points in my journey to feeling established and comfortable as a
studier of science. Other experiences were included in this tale simply for their interesting or
educational qualities. Any lessons that may come from these, however, I will leave for the reader
to tease out. Above all else, I am simply trying to tell the facts, though some of the names have
been changed. But, for fear the reader might get unduly high hopes for what is to come, I will say
no more.

An awkward silence jarred the closing of the initiation. Sensing a faux pas, both the
program directors and the budding scientists they were in charge of looked at me with a sort of
curious pity. Was it really that unusual to suggest the members of my medical research program
get to know one another by having a tea party? I was once again reminded that my exposure to
science had not fully converted me into a "science person." My heart, intricate and interesting
device though it may be, still pumped the blood of an English major. Though I loved this fact, it
amplified my fear that I was in over my head.
Two years earlier I had added a B.S. to my degree in English and begun a vigorous frolic
through the biology and chemistry courses OBU offered. Eventually, the time came for me to
apply to research opportunities. Due to their highly sequential nature and my accelerated
timetable, I had not had many classes that would have aided me in comprehending my research.
Micro- and cellular biology, genetics, and biochemistry all lay ahead of me. The resulting
conceptual deficiency made it difficult to decipher even the projects to which I was applying.
Trying to be diligent, I researched countless topics before applying to the programs they
concerned. Even though I felt compelled to state the gaps in my knowledge, I somehow got
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accepted into a few programs, and I settled on joining Dr. Steven Barger's Alzheimer's research
at the University of Arkansas for Medical Sciences.
Dr. Barger was studying the effects of different isoforms of ape lipoprotein E on the
uptake of amyloid beta plaques by rat microglia. Microglia! A word I recognized! Looking to get
a head start, I requested Dr. Barger send me some primer reading to help me get oriented. He did
so in the form of several journal articles. After spending two weeks trying to translate sixty pages
of what seemed to be a highly obscure English dialect, I was perfectly oriented. I knew right
where I stood-six feet under the waters of perplexity.
The start date rolled around, though, and I moved into the dorms at DAMS. A few days
later, I was at the initiation, frantically trying to think of a way to tell science folk that nothing
breaks ice better than hot-water infusions. To my great relief, the gal next to me, one Miss
Distefano, piped up with the enthusiastic acceptance of the idea of a tea party. She never came to
a single one, but I owe her much for this initial embrace. A little while later, I was picking my
mentor out of a lineup across the table and trying to figure out how to initiate conversation.
I do not remember exactly how I did that, but soon we were walking through the
labyrinthine buildings on the way to Dr. Barger's lab. Our conversation naturally turned to the
literature he had sent me. I told him that the shorter articles held my attention like good pageturners, keeping me interested in seeing how they would tum out. Upon hearing this, he rightly
seemed surprised and tickled. It was a bit harder to classify his response when I told him that the
longer articles had remained absolutely impenetrable to me.
Less than three minutes after setting foot in his lab for the first time, I was ecstatically
looking at living microglia under a microscope. Having only encountered microglia in text, I
elatedly tried to fathom that scientists could extract microglia from the brain of a rat and keep

6
them alive and replicating in flasks. Sheepishly, I admitted that I knew nigh nothing of the
electrophoresis, polymerase chain reaction, and the other laboratory procedures he had casually
brought up. I simply had not had the classes yet. In response to my concern, he said seven words
that would change the entire way I approached the summer: "I'm going to assume you know
nothing."
Those seven words freed me from having to meet anyone else's expectations, allowing
me to focus on my own. In retrospect, this might have increased my work load. I wanted to learn
everything I could from this opportunity, so I asked infinite questions, investigated every
instrument, and accosted everyone in the surrounding labs. When Dr. Barger began training a
volunteer in the evenings after our work was finished, I would hover about, gleaning all I could
from their projects. This pesky curiosity usually led to my work days being 12-14 hours long, but
Dr. Barger's were always longer.
Though long, the days were not entirely filled with work. Especially early on, many
hours were spent standing cross-armed outside my cubical, discussing the philosophical, ethical,
and political implications of science; the physiological explanations of biological phenomena;
and the joys of the outdoors and music. There were also frequent meetings with my fellow
program members, and even more excitingly, I was allowed to attend the weekly
interdisciplinary meetings that my lab participated in.
As I became more competent in the lab, I was eventually able to do much of the up-keep
of the microglia. I could come in on the weekend and feed or collect the cells, while playing
music unabashedly. I could plate harvested cells at a desired concentration and prepare
treatments for them. I could even extract their DNA and assess its purity with various
instruments. After I was taught different techniques and protocols, I would retreat to my cubical
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to research the concepts behind them. I found myself perpetually awed by the simple creativity
employed by scientists when they make the seemingly impossible possible.
The days were not devoid of their stresses, of course. I spent many sleep-deprived hours
in my cubical, listening to the incessant whining of my tinnitus as I strained to figure out
concepts which were well beyond my comprehension. To remedy the tedium, I would
occasionally adjourn to one of the scenic outdoor benches around campus and continue my work
while watching a storm roll in. During these times, I felt most sharply the loss of calluses, scars,
and physical exertion that were associated with my adventures as an English major. As a biology
major I learned how muscles worked, but I rarely got to use mine. It was extremely enjoyable to
work in a lab that had been pulled straight out of the first scene of a zombie movie, but I found
the lack of being outdoors taxing.
Other stressful situations arose when I did something clumsy, either physically or
mentally. Whenever I'd forget to put the lid on the centrifuge, spill or contaminate a culture, or
misdo a dilution, my fellow lab members would always put the incident into perspective by
sharing tales of all the things they had messed up in the past.
Weeks of thrilling monotony passed, dusted throughout with papers, presentations,
dinners, concerts, and roving adventures. Before I knew it, it was time to get my poster printed
for my final presentation. I sat in my cubical for 14 hours straight, listening to Trampled by
Turtles and trying to connect the different facets of our research into coherent findings. The
poster was printed, and the next day I was setting it up. In spite of all I had learned, I was still
pointedly aware of my vast ignorance regarding how my project fit into the grand scheme of
things. The work that I had done was only a fraction of Dr. Barger's overall project, a fact that
made seeing the grand scheme difficult.
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Before I had a chance to review my poster, a small, balding man walked up and said,
"I'm Dr. Smith. I went to Harvard." My head involuntarily cocked sideways and one eye
narrowed as I tried to grasp the relevance of his statement. He asked several very precise
questions, but before I had finished answering them, he moved on to critiquing the methods and
patterns of some of the people I worked with. Then he trailed into talking about research he had
done that was tangentially related to mine. Then he left, and I was disheartened. Was this how
real scientists behaved? Did many of them have such inflated egos and such a competitive spirit?
I did not have long to ponder these questions, because soon after the old man left, a
young, long-haired kid named Jarrett came up. I believe he was a sophomore at Hendrix. After
eyeing my poster from a distance, he came into range. I pounced at him energetically, asking if
he would like to hear my spiel. Through a timid smile, he told me that he would prefer to read
over it himself first. For a moment he did. Then, speaking softly, he said that he had been
interested in Alzheimer's for a while and had been doing some personal research into it. We
relayed what we knew of the disease, each filling in the gaps in the other's knowledge. Into this
review he incorporated a number of thought-provoking questions about my research, using his
fresh perspective and different experience to make connections I hitherto had not.
This encouraging encounter set the tone for the rest of the poster session. Though I felt as
though I didn't understand the grand scheme of my research when I started, as I repeatedly
explained it to people, answered their questions, and heard their comments, the logic of it all fell
into place. By the end of the session, I was pumped about my research, and sad to see it go. That
night, instead of letting me finish off my written report, my lab took me out for a going-away
party. I left for home the next day, amid invitations to return to visit labs and houses and even to
make jelly.
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As soon as I was out ofthe lab and back at school, the memories of my research rapidly
began to degrade. This was unfortunate, as several months later, when I had had time to
thoroughly forget the workings of my project, I had to present again. This time it was at the
University of Arkansas. Though I had intended to review my poster before I went, I didn't get a
chance to until the night before. When I began to look over it, I realized that I was once more
entirely lost, and I regretted ever signing up to present again. In a small panic, I lamely stayed up
late into the night nervously reviewing the PDF version of my poster instead of joining the rest
of my program's members for a night on the town.
As I began to present the next morning, the anxiety produced by my perceived ignorance
had not dispersed. Though I had spent half the night preparing, I still felt as though I were
winging it with the butterflies in my stomach. As before, however, my sleep deprivation and
stress gave way to a thrilled enthusiasm as people asked questions and provided insights. It
would seem that this enthusiasm was contagious, because the judges ended up awarding me first
place out of the 84 biology poster presentations. I still feel as though my enthusiasm gave me an
unfair advantage, but I could not help it!
This recently happened again when I was able to go with a group from OBU to the
National ACS Conference in Denver. There, in addition to being able to watch tons of
enlightening lectures, I was able to present my research again. I ran through another cycle of
panicking and getting an award.
That brings us just about up to the present, as far as my research is concerned.
Cumulatively, this experience has encouraged me in my pursuit of science and led me from
being an uncertain Englishy science person to one both humbled and inspired by the "many great
Regions [to be] discouered." Though, according to my standards, I am a long way off from
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general scientific competence, my experience with research has shown me that persistence and
curiosity is a viable way to pursue this goal.
To effect an even more merry conclusion, I will resolve the stress with which I opened.
During the course ofthe summer, I was able to conjure the scientists, young and old, to
numerous tea parties. Some came hesitantly, picturing polite society and fancy teaware, but they
soon learned that I do not do daint. Most of the tea parties were held in the lobby of my dorm.
There, people from all over the world congregated with teas from their homelands and beyond.
Sometimes we would talk for over six hours, sitting amid the chaotic collection of teas, pastries,
and cheeses that was strewn over the couches and ping-pong table. Sipping out of mismatched
mugs, we would discuss our research, theories, and interests. People would come and go as they
pleased. Often strangers passing through the lobbies would stop for a while to see what was
going on and tell us what they had seen that night while working in the emergency room.
We also enjoyed having more exclusive tea times in a conference room that overlooked
the campus from the fifth floor of my lab building. On one such occasion, a friend and I talked
late into the night with Dr. Barger as he sipped on tea I had collected from the woods of
Arkadelphia.
You might condemn this ending as out-of-order or irrelevant to my research, but above
all else, it was experiences like these that proved to me that the English and the scientific halves
of my heart could work together. Science functions as the left half of my heart, driving me and
invigorating my body and mind, while English functions as the right half, replenishing my lifeforce and reminding me to breathe. It is only in the collaboration of these two halves that I thrive,
and it was this summer research experience that showed me just how well they mesh.
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The Effects of Apolipoprotein E on M2 Microglia
Baronger Dowell Bieger, Ouachita Baptist University
Arkadelphia, Arkansas

Abstract
The primary genetic risk determinant for late-onset Alzheimer's disease (LOAD) is
the apolipoprotein E gene (APOE). Variations in this gene produce three different isoforms
of the apolipoprotein E protein (A poE): ApoE2, ApoE3, and ApoE4. ApoE3 is the most
common isoform, so rates of LOAD among other genotypes are indexed to this variant.
ApoE2 is rather rare, but its carriers are less likely to get LOAD; when they do, they get it
later. The second most common variant is ApoE4, and its carriers are significantly more
likely to get LOAD. They also tend to succumb earlier. Once developed, LOAD is
characterized by inflammation-related (Ml) changes in microglia, non-neuronal cells that
mediate innate immunity in the central nervous system (CNS). Microglia are also capable
of expressing gene products associated with an alternative, non-inflammatory (M2) form of
activation in the periphery, but the degree to which microglia recapitulate those peripheral
phenomena and the influence of LOAD etiology on the Ml-M2 spectrum remain to be
determined. Thus, identifying the effects of ApoE3 and ApoE4 on activated microglia could
be helpful in two important ways: 1) by elucidating the differences in activity between
ApoE3 and ApoE4 during LOAD and 2) by characterizing the Ml-M2 spectrum of
activation in the CNS. To explore these areas, we cultured primary microglia harvested
from neonatal rats and treated them with ApoE3, ApoE4, an M2 activator-interleukin4-or combinations thereof. We then measured expression ofM2 genes, phagocytic
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activity, and mitochondrial respiration. Preliminary results have shown substantial effects
of ApoE and IL-4 on all these parameters, notably, expression of CD33 and TREM2,
modulators of phagocytic activity, and other genetic determinants ofLOAD risk. Ongoing
experiments seek to further characterize these effects.

Introduction
Alzheimer's Disease (AD) is the most prevalent form of dementia (Ridge 2013). One of
the two best-known features of AD is the accumulation of plaques in the brain composing of
amyloid~ (A~)

peptide, a protein derivative with a natural tendency to self-aggregate into

oligomers and fibrils (Masters 2012).

A~

is a normal proteolytic product derived from the

processing of its larger amyloid precursor protein (APP), and while it can be over-produced in
rare cases of inherited forms of AD, the accumulation of A~ is typically a pathological result of
age-related failures in the mechanisms of removal (Figure 1) (Mandrekar 2009).
Microglia are macrophage-like cells that reside in the central nervous system (CNS) and
perform many of the same functions that macrophages do in the periphery, scavenging infectious
agents and insoluble debris (Lynch 2014). Microglia contribute to the normal clearance of A~.
Soluble AP is collected through macropinocytosis, but if the peptide has already formed
insoluble plaques, microglia collect the AP via phagocytosis (Mandrekar 2009).
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Figure 1: When the amyloid p regularly produced in neurons is not efficiently cleared by microglia, it
aggregates, eventually forming the plaques characteristic of LOAD. This study is aimed at understanding the
differences in microglial activity associated with different proteins known to be closely linked to LOAD. (Special
thanks to Ashley Keathley for making this lovely illustration.)

As with many other types of neurological disorders, an immune response plays a large
role in AD (Lynch 2014). Macrophages in the periphery are capable of a spectrum of immune
activation states ranging from Ml to M2 (or "classical" to "alternative") (Lynch 2014).
Generally, Ml is an inflammatory state that is known for causing collateral damage to healthy
tissue in its effort to combat invaders. M2, however, is non-inflammatory and is associated with
tissue repair. Ml is often induced by molecules produced by infectious pathogens and facilitates
phagocytic activity, whereas M2 is typically induced by host-produced cytokines such as
interleukin-4 (IL-4) and has been proposed to be counter-productive to the role microglia play in
clearing A~ from the brain (Sudduth 2013). Though the immune spectrum in the periphery has
been well characterized, the extent to which the CNS 's immune spectrum is analogous to the
periphery's is still being determined (Wilcock 2011).
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Late onset AD proved hard to predict genetically. In 1992, however, the apolipoprotein E
gene (APOE) was discovered to have three variants that correlated strongly with varying degrees
of risk for developing late onset AD. APOE3 is the most common allele, and so is associated
with the baseline rates of AD. People with an APOE2 allele, the rarest form, are much less likely
to get AD than those homozygous for APOE3, and if they do get it, it is generally later in life.
Those with an APOE4 allele, on the other hand, have a higher probability of getting AD earlier
than those with APOE3 (Roses 1997). It is important to note, though, that all the APOE alleles
are producing useful apolipoprotein E proteins (ApoE). These proteins play a key role in
metabolism and the distribution of cholesterol and other lipids to neurons, especially under
conditions of injury or other stress (Horsburgh 2000).
To begin characterizing the influences of ApoE genotype on the M1-M2 spectrum in
micoglia, we treated rat primary microglia with IL-4, Apo£3, and ApoE4, alone and in
combination. The oxidative metabolism of microglia was assessed using a Seahorse Bioscience
Extracellular Flux Analyzer. Quantitative real-time polymerase chain reaction (qRT-PCR) was
performed to measure the expression ofM2 markers such as arginase 1 (ARG1), chitinase 3-like
1 (Ch3L1), and mannose receptor C1 (MRC1) (Chhor 2013). We also measured expression of
CD33 and the triggering receptor expressed on myeloid cells 2 gene (TREM2). An increase in
CD33 is associated with suppressed phagocytic activity (Griciuc 2013), while increased levels of
TREM2 have been found to promote the phagocytic breakdown of A~ (Jiang 2014). Finally, we
directly assessed the ability of microglia to internalize A~ after pretreatment with IL-4, Apo£3,
ApoE4, or their combination.
The purpose of this study is twofold. Its primary goal is to tease apart the differences in
microglial response to ApoE3 and ApoE4, both by themselves and accompanied by an M2
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inducer. Since these isoforms are so closely tethered to AD risk, any differences in effects could
help elucidate the harmful aspects of ApoE4. A secondary benefit is that our study deals with the
relatively understudied M1-M2 spectrum ofthe CNS. Consequently, our results could help
develop a clearer image of immune activation in the CNS.

Experimental Procedures
Primary microglia
Cerebral cortices were removed from neonatal (P0-2) Sprague-Dawley rat pups and
dissociated by trituration and digestion in trypsin (1 mg/ml). The dissociated cell suspension
from each neonate was plated in 75-mm flasks in minimum essential medium (MEM) containing
10% fetal bovine serum (FBS) and gentamycin (10 ).lg/ml). Cultures were incubated at 37 oc in a
humidified incubator with 5% C02 approximately 12 days. Microglia were then physically
dislodged from the astrocyte monolayer by sharp blows to the sides of the flasks and collected
by centrifugation at 800 rpm for 10 min. The supernatant was aspirated away, leaving ~4 mL per
conical left. The cells were then resuspended in the existing medium and counted on a
hemacytometer.
Microglia were plated in MEM/FBS at approximately 150,000 cells/well in 96-well
Seahorse plates, 350,000 cells/well in 24-well plates (for A~ uptake assays), or 106 cells/35-mm
plate (for RNA isolation). After 24 h, the culture medium was washed to serum-free MEM/Fl2
(1: 1), and microglia were incubated an additional 18-22 h with the following: 40 ng/ml IL-4, 30

nM ApoE3 , 30 nM ApoE4, or combinations of the IL-4 treatment with each of the ApoE's.
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Production of recombinant ApoE
The T98G human astroglioma cell line was stably transfected with plasmids encoding
ApoE3 or ApoE4. Cultures were incubated 96 h in MEMIF12 supplemented with 0.5 mM Lglutamine, 10 nM Na selenite, and 50 J..LM ethanolamine. After clearing by centrifugation,
conditioned medium was concentrated through two steps: first on Centricon Plus-70 and second
on Amicon Ultra-4 filters (both with a 10-kDa cutoff), ultimately achieving ~2000-fold
concentration. This concentrate was resolved on a Superdex 200 10/300 GL column (mobile
phase: 20 mM NaP04, pH 7.5, 50 mM NaCl, 1 mM EDTA). Fractions were analyzed by western
blot for ApoE and by Coomassie staining for total protein; fractions highest in ApoE and lacking
other visible protein contaminants were pooled, sterile-filtered, and quantified by immunoblot
comparison against standards comprising highly purified ApoE.

qRT-PCR
Microglia to be used in qRT-PCR were plated in 35-mm dishes (Falcon). After treatment,
the RNA was purified using the QIAGEN RNeasy Mini Kit Plus according to manufacturer's
directions. (It should be noted that the optional drying spin after the final column wash was
performed and the RNA elution was performed with one volume of30 J..Ll.) The isolated RNA
was then quantified either by spectrophotometry or use of a LabChip with Agilent
Technologies's 2100 Bioanalyzer. Reverse transcription was performed on 200 or 250 ng of
RNA using the ImProm II Reverse Transcription System (Promega) with random primers.
Finally, qRT-PCR was performed with SYBR Green mix (Applied Biosystems) and primers for
CD33, MRCl, Ch3Ll, ARGl, and TREM2; ISS rRNA was also quantified as an internal
reference. The eDNA was amplified on an Applied Biosystems 7900HT Fast thermocycler, and
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quantitation was achieved by interpolation in a standard curve produced from a mixture of all
samples.

Seahorse
The oxidative metabolism of microglia was assessed using a Seahorse Bioscience
Extracellular Flux Analyzer (Figure 2). This instrument characterizes various aspects of cells'
metabolism by monitoring their oxygen consumption and acid production while injecting drugs
that isolate various aspects of mitochondrial respiration. The analysis was performed as three 3min measurements of02 consumption under each of the following conditions: initial (no
addition), oligomycin (1.5 f.!M), carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP;
0.7 f.!M), and antimycin A/rotenone (0.75/1.5 f.!M). The timepoint achieving greatest average
magnitude of effect for each condition was selected. Respiration after antimycin A/rotenone was
considered non-mitochondrial respiration. The difference between this and the initial reading was
considered basal mitochondrial respiration. The difference between initial and oligomycin
readings was considered ATP-linked. The difference between non-mitochondrial and FCCP
readings was considered maximal mitochondrial respiration.
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Figure 2: After monitoring their basal respiration, oligomycin is injected to inhibit respiration tied
to ATP. Once this state is documented, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) is
used to relax the inner mitochondrial membrane's proton gradient, permitting maximal respiration. Finally,
antimycin A and rotenone are added to inhibit complexes III and I, respectively. These drugs disrupt the
electron transport chain, providing a measure of oxygen consumption that is not related to the mitochondria
(Rose 2014).

Af3-uptake assays
A~

(22 nmol) and A~-HiLyte488 (4.4 nmol) were dissolved in hexafluoroisopropanol,

dessicated, resuspended at 2 mM in anhydrous dimethylsulfoxide, then incubated 30 h in phenol
red-free F12 medium at 4 °C at 150 f.J.M. (These conditions favor the formation of oligomers,
soluble aggregates of2-15 molecules of A~.) Primary microglia were plated at 350,000/well in
24-well plates and seated overnight in MEM/10% FBS. Microglia were washed to serum-free
MEM (3X) and treated with ApoE and IL-4 for 18 h. Microglia were washed again (2X) and the
A~

mixture was applied. After 12 h, a 25-f.l.l aliquot of medium was removed, diluted with 75 f.l.l
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PBS, and read on a FITC channel on a fluorescent plate reader. (Three pre-reads were made
with PBS alone to establish a background reading for each well. All readings were made in the
same black 96-well plate, with each fraction of the same original culture well in a consistent
reading-plate well throughout.) Cells were washed briefly with PBS then exposed to 200 !Jl of an
acid wash solution consisting of0.2 M acetic acid and 0.5 M NaCl at 4 °C for 15 min. 100 !Jl of
this solution was assessed for fluorescence. Cells were washed briefly with 50 !Jl PBS. 50 !Jl of
radioimmunoprecipitation buffer (20 mM phosphate buffer, pH 7.4, 150 mM NaCl, 2 mM
EDTA; 1% NP-40; 1% sodium deoxycholate) was then applied, and the plate was frozen. The
plate was thawed and each well was scraped with a cell scraper cut down to fit in a 24-well. The
lysate was centrifuged at 16,000 xg for 10 min, and the entire supernatant was diluted in 50 !Jl
PBS and read in the plate reader. The pellets were dissolved in 100 !Jl 70% formic acid for 60
min at room temp.; the entire 100 !Jl was read in the plate reader. Readings were subtracted by
the background, and each fraction was multiplied by its dilution factor in the fluorescence
reading (1 for the formic acid fraction). These adjusted values were summed for each well, and
the data are expressed as a percent of the total.

Results and Discussion
Seahorse
The first thing to note about the data shown in Figure 3 is that, across all treatments, the
maximal respiration is less than the basal respiration. This seems unusual given Figure 2. We
speculate, however, that the oligomycin actually killed many of the cells. This seems unusual, as
the concentrations used are standard in such assays. If such results continue to be found with
microglia, we might opt to do a dose-response curve with oligomycin, while monitoring cell
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viability. This Seahorse dataset is still valuable, though, as it is readily seen that some treatments
remained healthier throughout the injections.
For instance, the Seahorse assay highlights the increase in metabolism produced by
ApoE, especially in conjunction with IL-4. Though IL-4 has been associated with trophic effects
(Araujo 1993, Soria 2011), it did not show much effect on the mitotic respiration until combined
with A poE. Then the effects are substantial. Regardless of M2 activation, the addition of ApoE
increased metabolism. This suggests increased cell health and robustness, though it is also
possible that the elevated levels of respiration represent a response to the stress of activation. To
wit, IL-4 also elevated the leak-associated respiration, a parameter associated with a loss of
integrity of the mitochondrial membrane, resulting in 02 consumption that is less efficient with
regard to ATP production.
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Figure 3: Mitochondrial respiration as impacted by ApoE. Microglia were treated as indicated and
then subjected to assays of mitochondrial oxygen consumption by Seahorse technology (see Methods).
Components of respiration are indicated below each grouping. All treatments were significantly different
from control except IL-4 in the basal, ATP-linked, and leak components (t = p<0.05 vs ApoE + IL-4, n.s. =
not significant)
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qRT-PCR
As expected, our preliminary data have shown an increase in gene expression of the M2
indicators ARG1, Ch3L1, and MRC1 in the IL-4 treatment (Figure 4). ApoE3 tended to suppress
the M2 activation state, as indicated by its effects on these three genes. The fact that ApoE4 did
not exhibit this suppression of ARG 1 and Ch3 L 1 is potentially significant and could prove to be
a clue to what ApoE4 is doing differently that elevates AD risk. For example, as an M2 state is
hypothesized to suppress phagocytic activity and thereby allow A~ buildup in the brain
(Wilcock 2011 ), the lack of M2 suppression seen in ApoE4 might be part of the reason it is
associated with greater A~ deposition and greater risk of AD. However, in MRC1, the same
mitigation of IL-4-associated M2 that is seen in ApoE3 is seen with ApoE4. Overall, the
differing expression of these M2 markers demonstrates that the interactions between ApoE and
the M2 state are complex and emphasize the importance of testing a wide range of markers to
comprehensively elucidate the impact of ApoE.
The expression ofCD33 was found to be increased in treatments with ApoE and
decreased with those in an M2 state, effects that seem largely to cancel each other out when
combined (Figure 5). CD33 expression levels appear to be inversely correlated with A~
clearance by microglia (Griciuc 2013). However, the implication that IL-4 suppression ofCD33
would increase phagocytosis is hard to reconcile with other evidence that an M2 state promotes
the buildup of A~ plaques (Wilcock 2011 ). This may indicate that the clearance of AP by
microglia is not entirely dependent on classical phagocytic mechanisms (see below).
The situation is made even more intriguing by the fact that the relative expression of
TREM2 across the treatments almost exactly mirrors that of CD33 (Figure 6). This is
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counterintuitive because TREM2 appears to facilitate the phagocytosis of A~ (Jiang 2014) while
CD33 appears to inhibit the phagocytosis of Af3. It is possible that one of these gene products
dominates the other, however, which could be tested by measuring phagocytic activity directly.
As the M2 state appears to be conducive to

A~

buildup, it is possible that the suppression of A~

phagocytosis associated with CD33 is less important than the ability ofTREM2 to enhance A~
clearance.

Gh3L1
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Figure 4: Influence of ApoE on M2-related gene expression. Microglia were treated as indicated
and RNA was isolated and subjected to qRT-PCR for ARGI (left), Ch3Ll (middle) or MRCl (right). A
limited number of replicates to date has obviated statistical analysis, but initial trends indicate that ApoE3
inhibits the effects ofiL-4, and ApoE4 may do the same for MRCL
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Figure 5: ApoE elevates expression ofCD33. Microglia were treated as indicated and RNA was
isolated for qRT-PCR ofCD33. ApoE3 and ApoE4 elevated expression of this phagocytosis inhibitor, and
IL-4 blocked the effects of both.
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Figure 6: TREM2 expression follows the same pattern as CD33, increasing with ApoE and
decreasing with IL-4.

24
A/3 uptake
ApoE is known to form complexes with A~ that influence the peptide's transport across
cellular membranes. To test the effects of ApoE on A~ uptake mechanisms that would be
independent of this role as a shuttle, we applied ApoE3 and ApoE4 to microglia as pretreatment
and washed them away prior to conducting A~ uptake assays. After a 12-h incubation with
fluorescently tagged A~ oligomers, microglia were subjected to an acid wash to remove surfacebound A~. Fractions of this wash showed no significant effect of the pretreatments (data not
shown).
After the acid wash, cells were lysed in a mild detergent. This lysate was cleared by
centrifugation;

A~

that was soluble in the supernatant, as well as the formic acid-extractable

insoluble material in the pellet, was quantified. These measurements indicated that ApoE evoked
stable changes in the microglia that favored

A~

uptake (Figure 7). Surprisingly, ApoE4 was

significantly more effective than ApoE3 in this regard. IL-4 reversed the effect of both ApoE's,
even though it had no impact on its own. As these findings reflect the uptake of A~, they seem at
first to conflict with the phagocytic activity as determined by CD33. This may be explained by
the fact that the A~ in this test was prepared as oligomers rather than insoluble fibrils. As such,
the microglia would be expected to take it up via macropinocytosis (Mandrekar 2009). This
process is independent of the molecules and mechanisms that mediate phagocytosis and thus
may also be independent of CD33. On the other hand, these influences on A~ uptake generally
mirror the effects of the ApoEs (and their reversal by IL-4) on TREM2 expression. Thus, it is
possible that the TREM2 plays a role in regulating AB uptake.
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Figure 7: ApoE4 increased the uptake of Ap. Microglia were treated with IL-4, ApoE, or combinations
thereof, then assayed for internalization of AP as described (Methods). Two fractions are reported: a detergentsoluble fraction obtained from the supernatants of celllysates and a fraction ("acid-soluble") liberated by formic
acid hydrolysis of material that was insoluble in the initiallysates. ApoE3 and ApoE4 increased the uptake and IL-4
blocked the effects of both.(*= p<0.05 vs control,**= p<O.Ol vs control,

tt = p<O.Ol vs ApoE + IL-4, ¥ = p<

0.05 vs ApoE4)

Conclusions
•

ApoE stimulated microglial respiration, and this was generally enhanced by IL-4, even
though IL-4 had no measurable effect on its own.

•

ApoE4 seems to interact with M2 activation differently than does ApoE3, according to
ARG 1 and Ch3Ll expression. ApoE3 may counteract the tendency of microglia to enter
the M2 state of activation. As the latter is associated with relatively poor phagocytic
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activity, this may mean ApoE3 carriers have generally lower rates of AD because their
microglia more efficiently remove

•

A~

aggregates.

The relative expressions of CD33 and TREM2, genes producing opposite effects on A~
phagocytosis, mirror each other across the treatments. This suggests a surprising
similarity in their contributions to the M2 phenotype.

•

ApoE3 is somewhat less effective than ApoE4 at inducing microglia to sequester soluble
A~.

While this seems counter-intuitive to the suppression ofM2 by ApoE3, it is possible

that this effect is limited to macropinocytosis of soluble A~ and that the effects on
insoluble aggregates require distinct processes of phagocytosis.

This is merely the tip of the iceberg, though. In the future, we are also interested in more
directly characterizing the phagocytic activity of the microglia, perhaps by monitoring latex bead
uptake. This would help us determine whether CD33 or TREM2 is dominating in this process.
Also, though the A~- uptake test was designed to measure A~ absorbed through
macropinocytosis, we would like to confirm the trends seen by experimental manipulation of the
macropinocytotic mechanism. This further testing would help us have a more solid
understanding of the role of ApoE and M2 activation have on phagocytic and macropinocytotic
clearance of A~.
As MRC 1 seems to display a different trend from the other M2 activators we
investigated, we could also test the expression of more genes and look into how ARG 1 and
Ch3Ll expression differs from that ofMRCl. These tests would help us determine whether the
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two genes gave us an accurate representation of the M2 activation in each treatment and help us
uncover the difference in ApoE3 and ApoE4 interactions with the M2 state. We might try to
determine if one gene is dominating the other through combined treatments with ApoE3 and
ApoE4. Finally, we would, of course, like to do more repetitions of these experiments to further
validate the data we have gathered thus far.
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